Regeneron Pharmaceuticals Inc Asset Turnover Ratio (REGN), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Regeneron Pharmaceuticals Inc   (NASDAQ: REGN)
 

Regeneron Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Regeneron Pharmaceuticals Inc asset turnover ratio, the ability of Regeneron Pharmaceuticals Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.38 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as REGN's position remain challenging.

Within sector 98 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 2406, from total ranking in the first quarter 2026 at 2797.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

REGN Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 9.19 % 8.85 % 17.74 % 16.68 % 15.09 %
Y / Y Revenue Change 16.73 % 19.04 % 2.51 % 0.9 % 3.62 %
Asset Turnover Ratio (TTM) 0.38 0.37 0.37 0.38 0.39
REGN's Total Ranking # 2406 # 2797 # 2464 # 2481 # 2515
Seq. Asset Change 2.11 % 0.76 % 0.97 % 5.1 % 1.8 %
Seq. Revenue Change 19.01 % -7.18 % 3.46 % 2.14 % 21.36 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 99
Healthcare Sector # 349
Overall Market # 2406

Asset Turnover Ratio Statistics
High Average Low
0.86 0.61 0.37
(Sep 30 2015)   (Dec 31 2025)




REGN Company Profile • Back to REGN Efficiency Comparisons • Compare REGN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
National Vision Holdings Inc   1.02 $ 2,033.426  Millions$ 1,986.531  Millions
Cerus Corporation  1.02 $ 221.224  Millions$ 216.285  Millions
Tandem Diabetes Care Inc   1.02 $ 1,037.302  Millions$ 1,015.840  Millions
Inspire Medical Systems inc   1.01 $ 899.227  Millions$ 888.101  Millions
National Healthcare Corp  1.01 $ 1,559.020  Millions$ 1,539.896  Millions
Madrigal Pharmaceuticals Inc   1.01 $ 1,283.940  Millions$ 1,273.505  Millions
Omada Health Inc   1.01 $ 308.445  Millions$ 305.974  Millions
Hims and Hers Health Inc   1.00 $ 2,578.494  Millions$ 2,570.967  Millions
Ensign Group Inc  1.00 $ 5,486.708  Millions$ 5,512.641  Millions
Corcept Therapeutics Inc  0.99 $ 830.813  Millions$ 840.960  Millions
Insulet Corporation  0.99 $ 3,053.400  Millions$ 3,093.000  Millions
Fortrea Holdings Inc   0.99 $ 2,676.500  Millions$ 2,714.025  Millions
Pacs Group Inc   0.99 $ 5,551.038  Millions$ 5,632.691  Millions
Onemednet Corporation  0.97 $ 1.590  Millions$ 1.632  Millions
Yunhong Green Cti Ltd   0.97 $ 20.662  Millions$ 21.225  Millions
Axogen inc   0.97 $ 251.174  Millions$ 258.110  Millions
Orthofix Medical Inc   0.97 $ 833.344  Millions$ 860.720  Millions
Neuropace Inc   0.97 $ 98.620  Millions$ 102.177  Millions
Brightspring Health Services Inc   0.95 $ 5,877.918  Millions$ 6,165.460  Millions
Ufp Technologies Inc   0.95 $ 632.042  Millions$ 666.123  Millions
Travere Therapeutics Inc   0.95 $ 591.330  Millions$ 624.580  Millions
Vaso Corporation  0.94 $ 80.220  Millions$ 85.428  Millions
Alnylam Pharmaceuticals Inc   0.94 $ 4,804.182  Millions$ 5,126.577  Millions
Apyx Medical Corp  0.94 $ 58.105  Millions$ 62.076  Millions
Community Health Systems Inc   0.93 $ 11,983.000  Millions$ 12,950.000  Millions
Rosecliff Acquisition Corp I  0.91 $ 16.467  Millions$ 18.038  Millions
Embecta Corp   0.91 $ 1,019.700  Millions$ 1,119.100  Millions
Genedx Holdings Corp   0.91 $ 455.446  Millions$ 501.350  Millions
Exelixis Inc   0.91 $ 2,435.920  Millions$ 2,688.949  Millions
Pediatrix Medical Group Inc   0.90 $ 1,950.625  Millions$ 2,161.685  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.